Nxn has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nexsen
- Nexsen Appoints Global Clinical Leader to the Board
- Quarterly Report - Q1 FY26
- Nexsen launches clinical trial for GBS Rapid Sensor
Later from Nexsen
- $500k govt grant expands GBS project to neonates
- Quarterly Report - Q2 FY26
- Half Yearly Report and Accounts
- FDA feedback derisks US approval pathway for StrepSure
- Nexsen accelerates global rollout for StrepSure
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen